The program seeks to prepare students for leadership positions in outcomes research within academia, industry, and government.

Our students receive full financial support, including a competitive stipend, paid tuition, and health insurance. They complete the PhD program in approximately five years, and our graduates have taken postdocs in prestigious colleges (at Harvard and Duke, just to name a few) and found desirable positions in academia and in the pharmaceutical industry. We meet many of our students for the first time during the School's Recruitment Weekend each January.

Recent Graduates

Brain Leinwand, PhD, whose dissertation was titled “The Cost-effectiveness of Treatments for Pediatric ADHD: The Effects of Gender and Comorbidity,” is working with Avalere Heath in the Health Economics and Outcomes Service Practice division.

Patrick Ryan, PhD, whose dissertation was titled "Enhancing Drug Safety though Active Surveillance of Observational Healthcare Data," is associate director of epidemiology at Johnson & Johnson Pharmaceutical Research and Development. He leads the epidemiology analytics group, which designs and analyzes studies across multiple disparate observational databases. He is also a research investigator for the Observational Medical Outcomes Partnership, a public private partnership managed by the FNIH and chaired by FDA to conduct methodological research to inform the national active medical product surveillance system.

Emma Wang, MHPA, PhD, whose dissertation was titled “The Effect of Adjunctive Psychotherapy on Health Related Outcomes Among Patients with Schizophrenia,” is a research economist at RTI-Health Solutions. She is working on projects from pharmaceutical companies using large data sets.